TrialPediatric research2020

Pharmacokinetics and short-term safety of the selective NOS inhibitor 2-iminobiotin in asphyxiated neonates treated with therapeutic hypothermia.

Laurent M A Favié et al.PubMed ↗Publisher ↗

No numbers read from the abstract.